DocGo (NASDAQ:DCGO – Get Free Report) and SeaStar Medical (NASDAQ:ICU – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, dividends, risk, institutional ownership and earnings.
Volatility & Risk
DocGo has a beta of 1.02, indicating that its share price is 2% more volatile than the S&P 500. Comparatively, SeaStar Medical has a beta of -1.05, indicating that its share price is 205% less volatile than the S&P 500.
Valuation and Earnings
This table compares DocGo and SeaStar Medical”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| DocGo | $322.20 million | 0.17 | -$182.40 million | ($1.91) | -0.29 |
| SeaStar Medical | $1.23 million | 16.00 | -$12.15 million | ($4.80) | -1.03 |
SeaStar Medical has lower revenue, but higher earnings than DocGo. SeaStar Medical is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
56.4% of DocGo shares are held by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are held by institutional investors. 3.8% of DocGo shares are held by company insiders. Comparatively, 0.7% of SeaStar Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Profitability
This table compares DocGo and SeaStar Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| DocGo | -62.23% | -44.09% | -29.14% |
| SeaStar Medical | -828.62% | -146.29% | -96.48% |
Analyst Ratings
This is a breakdown of current recommendations and price targets for DocGo and SeaStar Medical, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| DocGo | 1 | 2 | 3 | 0 | 2.33 |
| SeaStar Medical | 1 | 0 | 1 | 0 | 2.00 |
DocGo currently has a consensus target price of $2.38, indicating a potential upside of 327.47%. SeaStar Medical has a consensus target price of $8.00, indicating a potential upside of 62.60%. Given DocGo’s stronger consensus rating and higher possible upside, research analysts plainly believe DocGo is more favorable than SeaStar Medical.
Summary
DocGo beats SeaStar Medical on 12 of the 14 factors compared between the two stocks.
About DocGo
DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.
About SeaStar Medical
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
